Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nemaura Medical's share price for the quarter that ended in Dec. 2023 was $0.219. Nemaura Medical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 28.90 Mil. Therefore, Nemaura Medical's market cap for the quarter that ended in Dec. 2023 was $6.33 Mil.
Nemaura Medical's quarterly market cap
declined
from Jun. 2023 ($26.73 Mil) to Sep. 2023 ($9.10 Mil) and
declined
from Sep. 2023 ($9.10 Mil) to Dec. 2023 ($6.33 Mil).
Nemaura Medical's annual market cap
declined
from Mar. 2021 ($175.27 Mil) to Mar. 2022 ($105.33 Mil) and
declined
from Mar. 2022 ($105.33 Mil) to Mar. 2023 ($25.86 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nemaura Medical's Enterprise Value for Today is $0.00 Mil.
Nemaura Medical (OTCPK:NMRD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nemaura Medical Market Cap Related Terms
Nemaura Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Nemaura Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nemaura Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nemaura Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nemaura Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Nemaura Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nemaura Medical's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nemaura Medical (NMRD) has a Market Cap of $0.00 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nemaura Medical and its competitors.
Is Nemaura Medical's Market Cap too high?
Nemaura Medical's current Market Cap is $0.00 Mil.
How does Nemaura Medical's Market Cap compare to THMO and MOTS?
Nemaura Medical's Market Cap of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 118.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.39, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nemaura Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nemaura Medical's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nemaura Medical stock overvalued right now?
Nemaura Medical (NMRD) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nemaura Medical (NMRD), the current Market Cap is $0.00 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NMRD has been successfully added to your 